Frailty as measured by the Risk Analysis Index is associated with long-term death after carotid endarterectomy.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
11 2020
Historique:
received: 08 07 2019
accepted: 11 01 2020
pubmed: 15 3 2020
medline: 12 3 2021
entrez: 15 3 2020
Statut: ppublish

Résumé

The role of carotid endarterectomy (CEA) continues to be debated in the age of optimal medical therapy, particularly for patients with limited life expectancy. The Risk Analysis Index (RAI) measures frailty, a syndrome of decreased physiologic reserve, which increases vulnerability to adverse outcomes. The RAI better predicts surgical complications, nonhome discharge, and death than age or comorbidities alone. We sought to measure the association of frailty, as measured by the RAI, with postoperative in-hospital stroke, long-term stroke, and long-term survival after CEA. We also sought to determine how postoperative stroke interacts with frailty to alter survival trajectory after CEA. We queried the Vascular Quality Initiative CEA procedure and long-term data sets (2003-2017) for elective CEAs with complete RAI case information. For all analyses, the cohort was divided into asymptomatic and symptomatic carotid stenosis. Scoring was defined as not frail (RAI <30), frail (RAI 30-34), and very frail (RAI ≥35). Mortality information through December 2017 was obtained from the Social Security Death Index. Multivariable models (logistic and Cox proportional hazards regressions) were used to study the association of frail and very frail patients with the outcomes of interest. In a post hoc analysis, we created Kaplan-Meier curves to analyze patient mortality after CEA as well as after postoperative stroke. Of the 42,869 included patients, 17,092 (39.9%) were female, and 38,395 (89.6%) were white. There were 25,673 (59.9%) patients assigned to the asymptomatic stenosis group and 17,196 (40.1%) patients in the symptomatic stenosis group. Frailty was not associated with perioperative or long-term postoperative stroke. The risk of long-term mortality was significantly higher for frail (hazard ratio, 1.9 [1.7-2.3]) and very frail (hazard ratio, 3.1 [2.6-3.7]) asymptomatic patients; symptomatic frail and very frail patients also had a two to three times increased risk of long-term mortality. Frail and very frail patients had two to three times the risk for long-term mortality compared with patients who were not frail. Postoperative stroke negatively affected the mortality trajectory for all patients in the cohort, regardless of frailty status. RAI score is not associated with postoperative stroke; however, frail and very frail status is associated with decreased long-term survival in an incremental fashion based on increasing RAI. RAI assessment should be considered in the preoperative decision-making for patients undergoing CEA to ensure long-term survival and optimal surgical outcomes vs medical management.

Identifiants

pubmed: 32169359
pii: S0741-5214(20)30160-9
doi: 10.1016/j.jvs.2020.01.043
pmc: PMC10712269
mid: NIHMS1568969
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1735-1742.e3

Subventions

Organisme : NIA NIH HHS
ID : R03 AG050930
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

J Vasc Surg. 2015 Mar;61(3):683-9
pubmed: 25499711
Stat Med. 2004 Jul 15;23(13):2109-23
pubmed: 15211606
J Am Coll Surg. 2007 Jan;204(1):140-7
pubmed: 17189122
Stroke. 2012 Jul;43(7):1781-7
pubmed: 22550053
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
Stroke. 2015 Jan;46(1):7-8
pubmed: 25406149
J Vasc Surg. 2020 Jan;71(1):46-55.e4
pubmed: 31147116
Stroke. 2009 Oct;40(10):e573-83
pubmed: 19696421
J Vasc Surg. 2015 Feb;61(2):324-31
pubmed: 25312534
J Vasc Surg. 2016 Feb;63(2):345-54
pubmed: 26804216
JAMA Surg. 2017 Mar 1;152(3):233-240
pubmed: 27902826
Stroke. 2015 Nov;46(11):3288-301
pubmed: 26451020
J Am Coll Cardiol. 2011 Feb 22;57(8):1002-44
pubmed: 21288680
Int J Stroke. 2017 Oct;12(7):770-778
pubmed: 28462683
J Vasc Surg. 2017 Aug;66(2):433-444.e2
pubmed: 28583737
J Vasc Surg. 2019 Jan;69(1):104-109
pubmed: 29914828
J Vasc Surg. 2011 Sep;54(3):e1-31
pubmed: 21889701
Stroke. 2010 Jan;41(1):e11-7
pubmed: 19926843
JAMA Surg. 2017 Feb 1;152(2):175-182
pubmed: 27893030
JAMA Surg. 2019 Apr 1;154(4):336-344
pubmed: 30624562
Ann Surg. 2020 Dec;272(6):996-1005
pubmed: 30907757
Semin Vasc Surg. 2017 Mar;30(1):2-7
pubmed: 28818255
N Engl J Med. 2000 Jun 8;342(23):1693-700
pubmed: 10841871
JAMA Surg. 2020 Jan 1;155(1):e194620
pubmed: 31721994
Lancet Neurol. 2010 Jul;9(7):663-71
pubmed: 20554250
J Vasc Surg. 2013 Jul;58(1):112-8
pubmed: 23478502
N Engl J Med. 1998 Nov 12;339(20):1415-25
pubmed: 9811916
Eur J Vasc Endovasc Surg. 2012 Sep;44(3):252-9
pubmed: 22819739
N Engl J Med. 2010 Jul 1;363(1):11-23
pubmed: 20505173
JAMA Netw Open. 2019 May 3;2(5):e194330
pubmed: 31125103
N Engl J Med. 2016 Mar 17;374(11):1021-31
pubmed: 26890472
J Vasc Surg. 2010 Dec;52(6):1486-1496.e1-5
pubmed: 21146746
Ann Vasc Surg. 2016 Aug;35:19-29
pubmed: 27263810
J Vasc Surg. 2012 May;55(5):1529-37
pubmed: 22542349

Auteurs

Kara A Rothenberg (KA)

Stanford-Surgery Policy Improvement Research & Education Center, Stanford University, Stanford, Calif; Division of Vascular Surgery, Stanford University School of Medicine, Stanford, Calif; Department of Surgery, University of California San Francisco - East Bay, Oakland, Calif.

Elizabeth L George (EL)

Stanford-Surgery Policy Improvement Research & Education Center, Stanford University, Stanford, Calif; Division of Vascular Surgery, Stanford University School of Medicine, Stanford, Calif.

Nicolas Barreto (N)

Stanford-Surgery Policy Improvement Research & Education Center, Stanford University, Stanford, Calif.

Rui Chen (R)

Stanford-Surgery Policy Improvement Research & Education Center, Stanford University, Stanford, Calif.

Kaeli Samson (K)

Department of Biostatistics, University of Nebraska College of Medicine, Omaha, Neb.

Jason M Johanning (JM)

Department of Surgery, University of Nebraska College of Medicine, Omaha, Neb.

Amber W Trickey (AW)

Stanford-Surgery Policy Improvement Research & Education Center, Stanford University, Stanford, Calif.

Shipra Arya (S)

Stanford-Surgery Policy Improvement Research & Education Center, Stanford University, Stanford, Calif; Division of Vascular Surgery, Stanford University School of Medicine, Stanford, Calif; Surgical Service, VA Palo Alto Health Care System, Palo Alto, Calif. Electronic address: sarya1@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH